The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies
- 1 February 2017
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 228, 4-10
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Comparison of Beta-Blocker Effectiveness in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection FractionJournal of Cardiac Failure, 2013
- Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection FractionJACC, 2012
- Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: A propensity-adjusted case–control populational studyInternational Journal of Cardiology, 2011
- Effect of Beta-Blocker Therapy on Rehospitalization Rates in Women Versus Men With Heart Failure and Preserved Ejection FractionThe American Journal of Cardiology, 2010
- Effect of Statins, Angiotensin-Converting Enzyme Inhibitors, and Beta Blockers on Survival in Patients ≥65 Years of Age With Heart Failure and Preserved Left Ventricular Systolic FunctionThe American Journal of Cardiology, 2008
- Association of β-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS)American Heart Journal, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary articleJACC, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985